Gedeon Richter Plc.

Industry

  • Pharmaceuticals
    • Vaccines
    • Specialty Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
  • Biotechnology

Other Names/Subsidiaries

  • BCI Pharma
  • Finox
  • FINOX Biotech
  • Gedeon Richter Rxmidas
  • PregLem Holding
  • Richter Gedeon Vegyeszeti Gyar Nyrt
  • Richter-Helm
  • Richter-Helm BioTec
See more in Biomedtracker

Latest on Gedeon Richter Plc.

Generics Bulletin

Denosumab Race Heats Up In Europe With Eight More Nods

 
• By Dave Wallace

Four biosimilars sponsors – Biocon Biologics, Gedeon Richter, Mabxience and Zentiva – have each received dual positive opinions from the European Medicines Agency’s Committee for Medicinal Products fo

Pink Sheet

Semaglutide For MASH Among Raft Of New EU Filings

 
• By Neena Brizmohun

The European Medicines Agency has started reviewing for potential pan-EU marketing authorization 15 new drugs, including Novo Nordisk’s semaglutide for the treatment of non-cirrhotic metabolic dysfunc

Generics Bulletin

Richter Confirms European Tocilizumab Filing

 
• By Dean Rudge

Gedeon Richter has announced that a filing for its RGB-19 Mochida-partnered biosimilar rival to RoActemra (tocilizumab) has been accepted for review by the European Medicines Agency. “The submission o

Pink Sheet

New EU Filings Include First-Of-Its-Kind MS Drug Tolebrutinib & HIV Prophylaxis Lenacapavir

 
• By Neena Brizmohun

Tolebrutinib, Sanofi’s investigational treatment for non-relapsing secondary progressive multiple sclerosis (nrSPMS), is among the latest products that the European Medicines Agency has started review